RPS6KB1 and ovarian carcinoma: To investigate whether miR-497 overexpression enhanced the cisplatin response sensitivity of ovarian cancer cells via targeting mTOR and p70S6K1, we performed mTOR and p70S6K1 loss- and gain-of-function experiments in ovarian cancer cells.